Terms: = Brain cancer AND EZH2, ENX-1, 2146, ENSG00000106462, Q15910, MGC9169 AND Staging
2 results:
1. CCRK is a novel signalling hub exploitable in cancer immunotherapy.
Mok MT; Zhou J; Tang W; Zeng X; Oliver AW; Ward SE; Cheng AS
Pharmacol Ther; 2018 Jun; 186():138-151. PubMed ID: 29360538
[TBL] [Abstract] [Full Text] [Related]
2. Long non-coding RNA HOTAIR promotes glioblastoma cell cycle progression in an ezh2 dependent manner.
Zhang K; Sun X; Zhou X; Han L; Chen L; Shi Z; Zhang A; Ye M; Wang Q; Liu C; Wei J; Ren Y; Yang J; Zhang J; Pu P; Li M; Kang C
Oncotarget; 2015 Jan; 6(1):537-46. PubMed ID: 25428914
[TBL] [Abstract] [Full Text] [Related]
